Elsevier

Elsevier is a Dutch academic publishing company specializing in scientific, technical, and medical (STM) content. Founded in 1880 and headquartered in Amsterdam, Netherlands, it operates as a subsidiary of RELX, led by CEO Kumsal Bayazit, with a workforce of roughly 9,500 employees.

The company's portfolio is built around flagship journals and research platforms. Its products include journals such as The Lancet and Cell, the ScienceDirect collection of electronic journals, the Trends and Current Opinion series, the Scopus citation database, the SciVal research-performance tool, the ClinicalKey clinician search engine, and the ClinicalPath evidence-based cancer care service. Beyond publishing, Elsevier offers digital tools for data management, instruction, research analytics, and assessment.

Elsevier has a long history of digital innovation: in 1997, after nearly two decades of experiments, it launched ScienceDirect as the first online repository of electronic scientific books and articles, after which librarians and researchers increasingly migrated to e-only subscriptions. As a company whose business spans publishing and digital research platforms, innovations in this space are directly relevant to its products and operations.

Note: Reported revenue and income figures appear in secondary aggregations and should be confirmed against RELX's official annual reports before publication, as standalone subsidiary financials can be inconsistently reported.